Iacob DG - Search Results

1

Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis.

Iacob DG, Rosca A, Ruta SM. Iacob DG, et al. World J Gastroenterol. 2020 Mar 21;26(11):1113-1127. doi: 10.3748/wjg.v26.i11.1113. World J Gastroenterol. 2020. PMID: 32231417 Free PMC article. Review.

2

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Iacob SA, Iacob DG. Iacob SA, et al. Among authors: iacob dg. Front Endocrinol (Lausanne). 2022 Mar 9;13:814209. doi: 10.3389/fendo.2022.814209. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35355551 Free PMC article. Review.

3

Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores.

Iacob DG, Luminos M, Benea OE, Tudor AM, Olariu CM, Iacob SA, Ruta S. Iacob DG, et al. Front Med (Lausanne). 2022 Jul 29;9:888050. doi: 10.3389/fmed.2022.888050. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35966860 Free PMC article.

4

HIV-HBV Coinfection-Current Challenges for Virologic Monitoring.

Ruta S, Grecu L, Iacob D, Cernescu C, Sultana C. Ruta S, et al. Biomedicines. 2023 Apr 28;11(5):1306. doi: 10.3390/biomedicines11051306. Biomedicines. 2023. PMID: 37238976 Free PMC article. Review.

5

The human cathelicidin LL37 peptide has high plasma levels in B and C hepatitis related to viral activity but not to 25-hydroxyvitamin D plasma level.

Iacob SA, Panaitescu E, Iacob DG, Cojocaru M. Iacob SA, et al. Among authors: iacob dg. Rom J Intern Med. 2012 Jul-Sep;50(3):217-23. Rom J Intern Med. 2012. PMID: 23330289

6

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus.

Iacob S, Iacob DG. Iacob S, et al. Among authors: iacob dg. Front Pharmacol. 2020 Aug 26;11:1224. doi: 10.3389/fphar.2020.01224. eCollection 2020. Front Pharmacol. 2020. PMID: 32982720 Free PMC article. Review.

7

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis.

Iacob S, Iacob DG. Iacob S, et al. Among authors: iacob dg. Front Microbiol. 2019 Aug 7;10:1676. doi: 10.3389/fmicb.2019.01676. eCollection 2019. Front Microbiol. 2019. PMID: 31447793 Free PMC article. Review.

8

Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy.

Iacob SA, Iacob DG. Iacob SA, et al. Among authors: iacob dg. Front Microbiol. 2017 Nov 27;8:2323. doi: 10.3389/fmicb.2017.02323. eCollection 2017. Front Microbiol. 2017. PMID: 29230203 Free PMC article. Review.

9

Association of adiponectin/leptin ratio with carbohydrate and lipid metabolism parameters in HIV-infected patients during antiretroviral therapy.

Tiliscan C, Arama V, Mihailescu R, Munteanu D, Iacob DG, Popescu C, Catana R, Negru A, Lobodan A, Arama SS. Tiliscan C, et al. Among authors: iacob dg. Endocr Res. 2018 Aug;43(3):149-154. doi: 10.1080/07435800.2018.1439058. Epub 2018 Feb 16. Endocr Res. 2018. PMID: 29451987

10

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats.

Iacob S, Iacob DG, Luminos LM. Iacob S, et al. Among authors: iacob dg. Front Microbiol. 2019 Jan 23;9:3328. doi: 10.3389/fmicb.2018.03328. eCollection 2018. Front Microbiol. 2019. PMID: 30761120 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters